Heudorf Ursel, Weindel Martin, Wagenlehner Florian
MRE-Netz Rhein-Main, c/o Gesundheitsamt Frankfurt am Main, Frankfurt.
Laborarztpraxis Dres. med. Walther, Weindel und Kollegen, Frankfurt.
Aktuelle Urol. 2021 Aug;52(4):345-355. doi: 10.1055/a-1468-8212. Epub 2021 Jun 16.
In sight of increasing bacterial resistances, appropriate and cautious antibiotic therapy (antibiotic stewardship) is becoming more and more important, in private practices as well. A current S3 guideline is available for the treatment of uncomplicated urinary tract infections, which recommends that regular epidemiological examinations of pathogen sensitivity are to be carried out promptly and locally. With this said, the antibiotic prescriptions of the resident doctors in Hesse were examined and compared with the sensitivity of the most important pathogens causing urinary tract infections.
The prescription data for antibiotics (ATC J01) for the area of the Association of Statutory Health Insurance Physicians in Hessen for the years 2013 to 2020 were received from Insight Health GmbH & Co. KG, Waldems-Esch, which manages the data. A large laboratory that supplies numerous resident doctors in the Rhine-Main region provided sensitivity data tested according to CLSI until the year 2016 and from 2017 to EUCAST from microbiological examinations of urine samples for the clarification of community-acquired urinary tract infections from the years 2011-2020.
From 2013 to 2020 the antibiotic prescriptions decreased from 2 692 370 to 1 708 134 (minus 37 %). The prescriptions for cephalosporins were reduced by more than 40 %, those of quinolones by 76 %. Among the antibiotics recommended for urinary tract infections, the most common antibiotics used were fosfomycin (2020: 130 476), followed by co-trimoxazole (2020: 96 559), nitrofurantoin (2020: 37 415), trimethoprim (2020: 27 388), pivmecillinam (20 984) and nitroxoline (6818). Urologists, on the other hand, most frequently prescribed nitrofurantoin (2020: 9951) and co-trimoxazole (9772), followed by fosfomycin (7193), trimethoprim (5050), nitroxoline (3289) and pivmecillinam (2722). Despite the high use of fosfomycin in outpatient medicine, E. coli and Citrobacter spp. exhibited no loss of sensitivity, Proteus mirabilis and S. aureus showed a slight loss of activity, while in Enterobacter cloacae a clear loss of activity was seen. The E. coli strains detected from urine samples to clarify complicated urinary tract infections show continuously excellent sensitivity for fosfomycin, nitrofurantoin, nitroxoline and mecillinam (> > 90 %), whereas the sensitivity against trimethoprim was just under 80 %.
The decrease in antibiotic prescription data from statutory health insurance physicians in Hesse shows that the importance of cautious antibiotic therapy is also gaining ground in outpatient practice. Co-trimoxazole, which continues to be used very frequently, should be avoided in favor of monotherapy with trimethoprim because of the increased side effects of the sulfonamide component with the same effectiveness of trimethoprim. The E. coli strains detected from urine samples to clarify complicated urinary tract infections showed a sensitivity, of just under 80 % to trimethoprim. Since an approximately 10 % better sensitivity rate was found for uncomplicated community-acquired urinary tract infections that usually do not require microbiological diagnostics, in our opinion, in transferring this observation in the Rhine-Main area and in Hesse, trimethoprim can also continue to be used empirically for uncomplicated urinary tract infections.
鉴于细菌耐药性不断增加,适当且谨慎的抗生素治疗(抗生素管理)变得越来越重要,在私人诊所也是如此。目前有一份S3指南可用于治疗单纯性尿路感染,该指南建议应及时在当地对病原体敏感性进行定期流行病学检查。话虽如此,我们对黑森州住院医生的抗生素处方进行了检查,并与引起尿路感染的最重要病原体的敏感性进行了比较。
从管理数据的Insight Health GmbH & Co. KG(位于瓦尔德姆斯 - 埃施)获取了2013年至2020年黑森州法定医疗保险医生协会区域内抗生素(ATC J01)的处方数据。一家为莱茵 - 美因地区众多住院医生提供服务 的大型实验室提供了根据CLSI测试的敏感性数据,直到2016年,以及2017年至EUCAST的敏感性数据,这些数据来自2011 - 2020年用于明确社区获得性尿路感染的尿液样本微生物检查。
2013年至2020年,抗生素处方从2692370份减少到1708134份(减少了37%)。头孢菌素类药物的处方减少了40%以上,喹诺酮类药物的处方减少了76%。在推荐用于尿路感染的抗生素中,最常用的抗生素是磷霉素(2020年:130476份),其次是复方新诺明(2020年:96559份)、呋喃妥因(2020年:37415份)、甲氧苄啶(2020年:27388份)、匹美西林(20984份)和硝羟喹啉(6818份)。另一方面,泌尿科医生最常开具的是呋喃妥因(2020年:9951份)和复方新诺明(9772份),其次是磷霉素(7193份)、甲氧苄啶(5050份)、硝羟喹啉(3289份)和匹美西林(2722份)。尽管磷霉素在门诊医学中使用频繁,但大肠杆菌和柠檬酸杆菌属未表现出敏感性丧失,奇异变形杆菌和金黄色葡萄球菌表现出轻微的活性丧失,而阴沟肠杆菌则出现明显的活性丧失。从尿液样本中检测到的用于明确复杂性尿路感染的大肠杆菌菌株对磷霉素、呋喃妥因、硝羟喹啉和美西林表现出持续优异的敏感性(>>90%),而对甲氧苄啶的敏感性略低于80%。
黑森州法定医疗保险医生的抗生素处方数据下降表明,谨慎的抗生素治疗在门诊实践中的重要性也在增加。由于磺胺类成分副作用增加而甲氧苄啶效果相同,但复方新诺明仍频繁使用,因此应避免使用复方新诺明,而采用甲氧苄啶单药治疗。从尿液样本中检测到用于明确复杂性尿路感染的大肠杆菌菌株对甲氧苄啶的敏感性略低于80%。由于在通常不需要微生物诊断的单纯性社区获得性尿路感染中发现敏感性率约高10%,因此我们认为,在将这一观察结果推广到莱茵 - 美因地区和黑森州时,甲氧苄啶也可继续用于单纯性尿路感染的经验性治疗。